-
1
-
2
A Comparative Parallel Study of Pharmacokinetics and Immunogenicity Following Single Intravenous Administration of Bevacizumab Biosimilar RPH-001 (Manufactured by R-Pharm Group, Russia) and Avastin® (Manufactured by F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Male Volunteers
Published 2019-09-01“…To assess and compare pharmacokinetics and immunogenicity (safety) following single intravenous administration of Avastin® (manufactured by F. Hoffmann-La Roche Ltd., Switzerland) and bevacizumab biosimilar RPH-001 (manufactured by R-Pharm Group, Russia).Materials and methods. …”
Get full text
Article -
3
-
4
Large-Scale Production of Human iPSC-Derived Macrophages for Drug Screening
Published 2020-07-01Get full text
Article -
5
High-throughput screening of BAM inhibitors in native membrane environment
Published 2023-09-01Get full text
Article -
6
The Evolving Landscape of Neuroscience Therapeutics: an Interplay of Multiple Modalities
Published 2024-02-01Get full text
Article -
7
Racial and ethnic diversity in global neuroscience clinical trials
Published 2024-02-01“…Methods: We retrospectively reviewed the F. Hoffmann-La Roche database for global, multicenter, neuroscience clinical trials from February 2016 to February 2021 and summarized and stratified race and ethnicity distributions by clinical trial therapeutic area and by country. …”
Get full text
Article -
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
TGFβ1 Induces Senescence and Attenuated VEGF Production in Retinal Pericytes
Published 2022-06-01Get full text
Article -
18
-
19
Translational PK/PD for the Development of Novel Antibiotics—A Drug Developer’s Perspective
Published 2024-01-01Get full text
Article -
20
Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosis
Published 2023-02-01Get full text
Article